Tele-yoga Program in COPD and Heart Failure
Overview
The combined diagnosis of chronic obstructive pulmonary disease (COPD) and heart failure (HF) is common but often missed because of similarities in clinical presentation, risk factors, and patient characteristics. The concurrent presence of both diseases worsens the limitations in exercise capacity and quality of life that patients experience with either disease alone. This pilot study will test the feasibility of a yoga program conducted in patients' homes using multi-point interactive videoconferencing ("Tele- Yoga") for patients with combined COPD/HF diagnoses. The investigators hypothesize that patients who receive a yoga program at home, compared to an educational control group, will experience fewer physical symptoms and better quality of life.
Full Title of Study: “Tele-Yoga for Chronic Obstructive Pulmonary Disease and Heart Failure Patients: A Pilot Study”
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Supportive Care
- Masking: Single (Outcomes Assessor)
- Study Primary Completion Date: December 2014
Interventions
- Behavioral: Yoga Program at home using internet technology
Arms, Groups and Cohorts
- Experimental: Yoga Program
- Yoga Program twice per week for 8 weeks
- Active Comparator: Education
- Education once per week for 8 weeks
Clinical Trial Outcome Measures
Primary Measures
- Feasibility of home yoga program as measured by the participants’ perception of the quality of the broadband connection.
- Time Frame: 8 weeks
- To evaluate the feasibility, acceptability, adherence rate of an 8-week, 1-hr biweekly Tele-Yoga intervention. Feasibility will be determined by the quality of the broadband connection, acceptability measured by participant satisfaction with the Yoga program and adherence measured by the number of times a participant participates in the yoga program.
Secondary Measures
- Physical Function
- Time Frame: 8 weeks
- Estimate the effect of home-based Tele-Yoga on physical function (endurance, balance, strength, and activity) and symptoms (dyspnea, sleep, and fatigue) compared to attention control
Participating in This Clinical Trial
Inclusion Criteria
- Patients with heart failure (HF) who also have COPD according to University of California San Francisco medical record documentation and would like to participate in a home yoga intervention and hospitalization within the past 24 months. – Patients must: receive permission from their provider to participate in the study – English-speaking – Score of 3 on the Mini-Cog test – Be between the ages of 40 and 85 years – New York Heart Association Class I-III left ventricular systolic or diastolic HF – Have moderate-severe COPD defined as post bronchodilator Forced Expiratory Volume (FEV1) in 1 sec < 80% predicted, FEV1/Forced Vital Capacity ratio < 70% and history of smoking – TV, broadband internet connection, enough space to practice yoga in front of the TV, and willing to have research assistant install videoconferencing equipment. Exclusion Criteria:
- Patients with a history of medication non-compliance as described by their provider – Hospitalization within the last 3 months – Myocardial infarction or recurrent angina within the last 6 months – Severe stenotic valvular disease – History of sudden cardiac death without subsequent automatic internal defibrillator placement – Cognitive impairment – Neuromuscular, orthopedic, or psychiatric illness that would interfere with yoga training – Oxygen saturation <85% on 6 liters of nasal oxygen.
Gender Eligibility: All
Minimum Age: 40 Years
Maximum Age: 85 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- University of California, San Francisco
- Provider of Information About this Clinical Study
- Sponsor
- Overall Official(s)
- Jill N Howie-Esquivel, PhD, Principal Investigator, University of California, San Francisco
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.